Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
35.98
-0.30 (-0.83%)
At close: Jun 3, 2026, 4:00 PM EDT
35.40
-0.58 (-1.61%)
After-hours: Jun 3, 2026, 7:22 PM EDT

Legend Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,6834,0155,96910,9388,3577,175
Market Cap Growth
24.57%-32.74%-45.43%30.89%16.46%92.11%
Enterprise Value
6,2383,4335,1049,8357,6956,613
Last Close Price
35.9821.7432.5460.1749.9246.61
PS Ratio
5.873.909.5238.3771.42104.26
PB Ratio
6.914.015.748.7411.239.37
P/TBV Ratio
6.914.015.748.7711.289.43
EV/Sales Ratio
5.483.348.1434.5065.7696.08
Debt / Equity Ratio
0.400.410.340.260.380.16
Net Debt / Equity Ratio
-0.46-0.53-0.74-0.78-1.00-0.99
Net Debt / EBITDA Ratio
3.564.212.621.891.661.97
Net Debt / FCF Ratio
3.854.154.882.373.343.16
Asset Turnover
0.710.610.360.180.100.08
Inventory Turnover
26.7929.4429.9135.3466.27176.58
Quick Ratio
2.011.884.496.773.594.11
Current Ratio
2.131.964.626.923.694.14
Return on Equity (ROE)
-25.19%-29.06%-15.45%-51.94%-59.11%-59.19%
Return on Assets (ROA)
-5.24%-5.01%-10.84%-20.76%-23.37%-26.75%
Return on Invested Capital (ROIC)
-27.20%-37.10%-113.02%-384.74%-9433.71%-770.35%
Return on Capital Employed (ROCE)
-12.40%-12.40%-21.90%-32.40%-44.30%-44.30%
Earnings Yield
-3.74%-7.39%-2.96%-4.74%-5.34%-5.62%
FCF Yield
-1.73%-3.21%-2.65%-3.78%-2.66%-3.35%
Buyback Yield / Dilution
-0.75%-0.80%-3.84%-10.71%-12.91%-19.21%
SEC Filings: 10-K · 10-Q